{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:35:59Z","timestamp":1782977759153,"version":"3.54.5"},"reference-count":26,"publisher":"American Association for Cancer Research (AACR)","issue":"8","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lynch syndrome is one of the most common hereditary cancer syndromes. Although Lynch syndrome is associated with increased risk for developing colorectal, endometrial, and other cancers specialized screening, risk-reducing surgery, and chemoprevention offer promise for reducing morbidity and mortality. Frequent colonoscopic surveillance has proven effective for early detection and prevention of Lynch syndrome-associated colorectal cancer; however, the optimal strategy for managing endometrial cancer risks in women with germline mutations in DNA mismatch repair genes has yet to be determined. In this issue of Cancer Prevention Research, Lu and colleagues report their findings of a phase II prospective, multicenter randomized trial comparing the effects of oral contraceptive pills and Depo-Provera on endometrial proliferation in women with Lynch syndrome. Although short-term hormonal treatment with either modality altered endometrial proliferation indices, it remains unknown whether hormonal suppression actually reduces endometrial cancer risk in women with Lynch syndrome. This trial represents the first of its kind in evaluating agents which might offer protection against Lynch syndrome-associated endometrial cancer and provides preliminary data regarding potential biomarkers for early detection of endometrial neoplasia. The investigators' experience with this trial also offers insights regarding the various technical and scientific challenges inherent in chemoprevention research. Cancer Prev Res; 6(8); 755\u20139. \u00a92013 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-13-0238","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T00:51:58Z","timestamp":1373503918000},"page":"755-759","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chemoprevention of Endometrial Cancer in Lynch Syndrome: A Step Forward"],"prefix":"10.1158","volume":"6","author":[{"given":"Elena M.","family":"Stoffel","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Internal Medicine, Cancer Genetics Clinic, University of Michigan Health System, Ann Arbor, Michigan; and 2Department of Obstetrics and Gynecology, Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Walsh","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Internal Medicine, Cancer Genetics Clinic, University of Michigan Health System, Ann Arbor, Michigan; and 2Department of Obstetrics and Gynecology, Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2013,8,4]]},"reference":[{"key":"2022060816175371100_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-10-0345","article-title":"The search for unaffected individuals with Lynch syndrome: do the ends justify the means?","volume":"4","author":"Hampel","year":"2011","journal-title":"Cancer Prev Res"},{"key":"2022060816175371100_bib2","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"2022060816175371100_bib3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","article-title":"Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome","volume":"137","author":"Stoffel","year":"2009","journal-title":"Gastroenterology"},{"key":"2022060816175371100_bib4","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","article-title":"Feasibility of screening for Lynch syndrome among patients with colorectal cancer","volume":"26","author":"Hampel","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022060816175371100_bib5","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1200\/JCO.2007.10.8597","article-title":"Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer","volume":"25","author":"Lu","year":"2007","journal-title":"J Clin Oncol"},{"key":"2022060816175371100_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1940-6207.CAPR-10-0262","article-title":"Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population","volume":"4","author":"Dinh","year":"2011","journal-title":"Cancer Prev Res"},{"key":"2022060816175371100_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","article-title":"EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet Med"},{"key":"2022060816175371100_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7326\/0003-4819-155-2-201107190-00002","article-title":"Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis","volume":"155","author":"Ladabaum","year":"2011","journal-title":"Ann Intern Med"},{"key":"2022060816175371100_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","article-title":"Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer","volume":"118","author":"J\u00e4rvinen","year":"2000","journal-title":"Gastroenterology"},{"key":"2022060816175371100_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.gastro.2005.11.032","article-title":"Decrease in mortality in Lynch syndrome families because of surveillance","volume":"130","author":"de Jong","year":"2006","journal-title":"Gastroenterology"},{"key":"2022060816175371100_bib11","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review","volume":"296","author":"Lindor","year":"2006","journal-title":"JAMA"},{"key":"2022060816175371100_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmg.2007.048991","article-title":"Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)","volume":"44","author":"Vasen","year":"2007","journal-title":"J Med Genet"},{"key":"2022060816175371100_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med"},{"key":"2022060816175371100_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ygyno.2012.08.031","article-title":"Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome","volume":"127","author":"Yurgelun","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2022060816175371100_bib15","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"2022060816175371100_bib16","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N Engl J Med"},{"key":"2022060816175371100_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"2022060816175371100_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM198003063021004","article-title":"Incidence of endometrial cancer in relation to the use of oral contraceptives","volume":"302","author":"Weiss","year":"1980","journal-title":"N Engl J Med"},{"key":"2022060816175371100_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"2022060816175371100_bib20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1158\/1940-6207.CAPR-13-0020","article-title":"Prospective, multi-center randomized intermediate biomarker study of oral contraceptive vs. Depo-Provera for prevention of endometrial cancer in women with Lynch syndrome","volume":"6","author":"Lu","year":"2013","journal-title":"Cancer Prev Res"},{"key":"2022060816175371100_bib21","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.4161\/cbt.8.22.9740","article-title":"Molecular clustering of endometrial carcinoma based on estrogen\u2013induced gene expression","volume":"8","author":"Westin","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"2022060816175371100_bib22","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1056\/NEJMoa0801297","article-title":"Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome","volume":"359","author":"Burn","year":"2008","journal-title":"N Engl J Med"},{"key":"2022060816175371100_bib23","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"2022060816175371100_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2012.10.005","article-title":"Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort","volume":"128","author":"Brasky","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2022060816175371100_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000341892","article-title":"Lynch syndrome: history, causes, diagnosis, treatment and prevention (CAPP2 trial)","volume":"30","author":"Burn","year":"2012","journal-title":"Dig Dis"},{"key":"2022060816175371100_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/6\/8\/755\/2252739\/755.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/6\/8\/755\/2252739\/755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T14:15:45Z","timestamp":1654697745000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/6\/8\/755\/50134\/Chemoprevention-of-Endometrial-Cancer-in-Lynch"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,4]]},"published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-13-0238","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22525101.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6544572.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22525101","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6544572","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]}}}